National

Germany gives Kiev tanks, missile launchers and anti-aircraft systems

Dec 24, 2024

Berlin [Germany], December 24: Ukraine has received an extensive new weapons package from Germany, the Defence Ministry in Kiev said on Monday.
The delivery, also confirmed by the German government, includes 15 Leopard 1 A5 battle tanks, two Gepard anti-aircraft tanks, a Panzerhaubitze 2000 self-propelled howitzer, two Iris-T anti-aircraft systems and two Patriot missile launchers.
The anti-aircraft systems are particularly important for Kiev to combat Russia's drone and missile attacks, which have intensified in recent weeks.
The German government says the delivery of the additional Iris-T systems had been promised in 2023.
Germany has now given Ukraine an additional 65,000 rounds of ammunition for the Gepard anti-aircraft tanks, as well as further ammunition for the Iris-T system.
In addition, Berlin has supplied AIM-9L/I Sidewinder air-to-air missiles, which enable fighter aircraft to attack targets in the air.
In addition to heavy weapons the new German package also includes trucks, drones, radar systems and ammunition. (DPA)
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025